Pancreatic α-cell dysfunction in diabetes

Diabetes and Metabolism

Volumn 34, Issue SUPPL. 2, 2008, Pages

  Burcelin, R ^a   Knauf, C ^a   Cani, P D ^a  

^a CHU RANGUEIL   (France)

Author keywords

Diabetes; Glucagon; Glucose sensor; hypoglycaemia

Indexed keywords

ADENOSINE TRIPHOSPHATE; ANTIDIABETIC AGENT; GLUCAGON LIKE PEPTIDE 1; GLUCAGONS; GLUCOINCRETIN; GLUCOSE; GLUCOSE TRANSPORTER 2; INCRETIN;

ARTICLE; DIABETES MELLITUS; DIET RESTRICTION; GLUCAGON BLOOD LEVEL; GLUCAGON RELEASE; GLUCOSE BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; HYPOTHESIS; IATROGENIC DISEASE; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS INSUFFICIENCY; PANCREAS ISLET ALPHA CELL; REGULATORY MECHANISM;

DIABETES MELLITUS; GLUCAGON; GLUCAGON-SECRETING CELLS; HUMANS; HYPERGLYCEMIA;

EID: 47149095990     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(08)73395-0     Document Type: Article

References (63)

1. Brownlee M. Negative consequences of glycation. Metabolism 49 (2000) 9-13
2. Unger R.H. Glucagon physiology and pathophysiology in the light of new advances. Diabetologia 28 (1985) 574-578
3. Dunning B.E., Foley J.E., and Ahrén B. Alpha cell function in health and disease: influence of glucagon-like peptide-1. Diabetologia 48 (2005) 1700-1713
4. Gerich J., Cryer P., and Rizza R. Hormonal mechanisms in acute glucose counterregulation: the relative role of glucagon, epinephrine, norepinephrine, growth hormone, and cortisol. Metabolism 29 (1990) 1164-1175
5. Frankel B.J., Gerich J.E., Hagura R., Fanska R.E., Gerritsen G.C., and Grodsky G.M. Abnormal secretion of insulin and glucagon by the in vitro perfused pancreas of the genetically diabetic Chinese hamster. J Clin Invest 53 (1974) 1637-1646
6. Gerich J.E., Charles M.A., and Grodsky G.M. Characterization of the effects of arginine and glucose on glucagon and insulin release from the perfused rat pancreas. J Clin Invest 54 (1974) 833-841
7. Olsen H.L., Theander S., Bokvist K., Buschard K., Wollheim C.B., and Gromada J. Glucose stimulates glucagon release in single rat alpha-cells by mechanisms that mirror the stimulus-secretion coupling in beta-cells. Endocrinology 146 (2005) 4861-4870
8. Barg S., Galvanovskis J., Gopel S.O., Rorsman P., and Eliasson L. Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. Diabetes 49 (2000) 1500-1510
9. Yoshimoto Y., Fukuyama Y., Horio Y., Inanobe A., Gotoh M., and Kurachi Y. Somatostatin induces hyperpolarization in pancreatic islet alpha cells by activating a G protein-gated K+ channel. FEBS Lett 444 (1999) 265-269
10. Gromada J., Bokvist K., Ding W.G., Barg S., Buschard K., Renstrom E., et al. Adrenaline stimulates glucagon secretion in pancreatic A-cells by increasing the Ca2+ current and the number of granules close to the L-type Ca2+ channels. J Gen Physiol 110 (1997) 217-228
11. Ronner P., Matschinsky F.M., Hang T.L., Epstein A.J., and Buettger C. Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-TC glucagonoma and beta-TC insulinoma cells. Diabetes 42 (1993) 1760-1772
12. Gromada J., Ma X., Hoy M., Bokvist K., Salehi A., Berggren P.O., et al. ATP-sensitive K+ channel-dependent regulation of glucagon release and electrical activity by glucose in wild-type and SUR1-/- mouse alpha-cells. Diabetes 53 Suppl 3 (2004) S181-S189
13. Xia F., Leung Y.M., Gaisano G., Gao X., Chen Y., Manning Fox J.E., et al. Targeting of KV4, CaV1. 2 and SNARE proteins to cholesterolrich lipid rafts in pancreatic alpha-cells:effects on glucagon stimulus-secretion coupling. Endocrinology 148 (2007) 2157-2167
14. Radke R., and Stach W. Innervation of the canine pancreas after vagotomy. Acta Anat (Basel) 127 (1986) 88-92
15. Pipeleers D.G., Schuit F.C., Van Schravendijk C.F., and Van de Winkel M. Interplay of nutrients and hormones in the regulation of glucagon release. Endocrinology 117 (1985) 817-823
16. Weir G.C., Knowlton S.D., Atkins R.F., McKennan K.X., and Martin D.B. Glucagon secretion from the perfused pancreas of streptozotocintreated rats. Diabetes 25 (1976) 275-282
17. Bonner-Weir S., and Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31 (1982) 883-889
18. Stagner J.I., and Samols E. Retrograde perfusion as a model for testing the relative effects of glucose versus insulin on the cell. J Clin Invest 77 (1986) 1034-1037
19. Unger R. insulin glucagon relationship in the defense against hypoglycaemia. Diabetes 32 (1983) 575-583
20. Diao J., Asghar Z., Chan C.B., and Wheeler M.B. Glucose-regulated glucagon secretion requires insulin receptor expression in pancreatic alpha-cells. J Biol Chem 280 (2005) 33487-33496
21. Zhou H., Zhang T., Harmon J.S., Bryan J., and Robertson R.P. Zinc, not insulin, regulates the rat alpha cell response to hypoglycaemia in vivo. Diabetes 56 (2007) 1107-1112
22. Burcelin R., and Thorens B. Evidence that extrapancreatic GLUT2-dependent glucose sensors control glucagon secretion. Diabetes 50 (2001) 1282-1289
23. Sorenson R.L., Garry D.G., and Brelje T.C. Structural and functional considerations of GABA in islets of Langerhans. Beta-cells and nerves. Diabetes 40 (1991) 1365-1374
24. Ahrén B. Autonomic regulation of islet hormone secretion--implications for health and disease. Diabetologia 43 (2000) 393-410
25. Schuit F.C., Huypens P., Heimberg H., and Pipeleers D.G. Glucose sensing in pancreatic beta-cells: a model for the study of other glucose-regulated cells in gut, pancreas, and hypothalamus. Diabetes 50 (2001) 1-11
26. Schuit F.C., and Pipeleers D.G. Differences in adrenergic recognition by pancreatic A and B cells. Science 232 (1986) 875-877
27. Rossi J., Santamaki P., Airaksinen M.S., and Herzig K.H. Parasympathetic innervation and function of endocrine pancreas requires the glial cell line-derived factor family receptor alpha2 (GFRalpha2). Diabetes 54 (2005) 1324-1330
28. Gromada J., Franklin I., and Wollheim C.B. Alpha-cells of the endocrine pancreas: 35 years of research but the enigma remains. Endocr Rev 28 (2007) 84-116
29. Ahrén B. GLP-1 and extra-islet effects. Horm Metab Res 36 (2004) 842-845
30. Creutzfeldt W.O., Kleine N., Willms B., Orskov C., Holst J.J., and Nauck M.A. Glucagonostatic actions and reduction of fasting hyperglycaemia by exogenous glucagon-like peptide I(7-36) amide in type I diabetic patients. Diabetes Care 19 (1996) 580-586
31. Behme M.T., Dupré J., and McDonald T.J. Glucagon-like peptide 1 improved glycaemic control in type 1 diabetes. BMC Endocr Disord 3 (2003) 3
32. Franklin I., Gromada J., Gjinovci A., Theander S., and Wollheim C.B. Betacell secretory products activate alpha-cell ATP-dependent potassium channels to inhibit glucagon release. Diabetes 54 (2005) 1808-1815
33. Heller R.S., Kieffer T.J., and Habener J.F. Insulinotropic glucagon-like peptide I receptor expression in glucagon-producing alpha-cells of the rat endocrine pancreas. Diabetes 46 (1997) 785-791
34. Ding W.G., Renstrom E., Rorsman P., Buschard K., and Gromada J. Glucagon-like peptide I and glucose-dependent insulinotropic polypeptide stimulate Ca2+ -induced secretion in rat alpha-cells by a protein kinase A-mediated mechanism. Diabetes 46 (1997) 792-800
35. Knauf C., Cani P., Perrin C., Iglesias M., Maury J., Bernard E., et al. Brain glucagon-like peptide-1 increases insulin secretion and muscle insulin resistance to favor hepatic glycogen storage. J Clin Invest 115 (2005) 3554-3563
36. Preitner F., Ibberson M., Franklin I., Binnert C., Pende M., Gjinovci A., et al. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 113 (2004) 635-645
37. Nakabayashi H., Nishizawa M., Nakagawa A., Takeda R., and Niijima A. Vagal hepatopancreatic reflex effect evoked by intraportal appearance of tGLP-1. Am J Physiol 271 (1996) E808-E813
38. Burcelin R. The incretins: a link between nutrients and well-being. Br J Nutr 93 Suppl 1 (2005) S147-S156
39. Burcelin R., Da Costa A., Drucker D., and Thorens B. Glucose competence of the hepatoportal vein sensor requires the presence of an activated glucagon-like peptide-1 receptor. Diabetes 50 (2001) 1720-1728
40. Taborsky G.J., Ahrén B., and Havel P.J. Autonomic mediation of glucagon secretion during hypoglycaemia: implications for impaired alphacell responses in type 1 diabetes. Diabetes 47 (1998) 995-1005
41. Gerich J.E., Langlois M., Noacco C., Karam J.H., and Forsham P.H. Lack of glucagon response to hypoglycaemia in diabetes: evidence for an intrinsic pancreatic alpha cell defect. Science 182 (1973) 171-173
42. Shi Z.Q., Rastogi K.S., Lekas M., Efendic S., Drucker D.J., and Vranic M. Glucagon response to hypoglycaemia is improved by insulin-independent restoration of normoglycaemia in diabetic rats. Endocrinology 137 (1996) 3193-3199
43. Fukuda M., Tanaka A., Tahara Y., Ikegami H., Yamamoto Y., Kumahara Y., et al. Correlation between minimal secretory capacity of pancreatic beta-cells and stability of diabetic control. Diabetes 37 (1988) 81-88
44. Raskin P., and Unger R.H. Effect of insulin therapy on the profiles of plasma immunoreactive glucagon in juvenile-type and adult-type diabetics. Diabetes 27 (1978) 411-419
45. Borghi V.C., Wajchenberg B.L., and Cesar F.P. Plasma glucagon suppressibility after oral glucose in obese subjects with normal and impaired glucose tolerance. Metabolism 33 (1984) 1068-1074
46. Reaven G.M., Chen Y.D., Golay A., Swislocki A.L., and Jaspan J.B. Documentation of hyperglucagonaemia throughout the day in nonobese and obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 64 (1987) 106-110
47. Hamaguchi T., Fukushima H., Uehara M., Wada S., Shirotani T., Kishikawa H., et al. Abnormal glucagon response to arginine and its normalization in obese hyperinsulinaemic patients with glucose intolerance: importance of insulin action on pancreatic alpha cells. Diabetologia 34 (1991) 801-806
48. Gastaldelli A, Baldi S, Pettiti M, Toschi E, Camastra S, Natali A, et al. Influence of obesity and type 2 diabetes on gluconeogenesis and glucose output in humans: a quantitative study. Diabetes 200;49:1367-73.
49. Unger R.H., Aguilar-Parada E., Muller W.A., and Eisentraut A.M. Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 49 (1970) 837-848
50. Aronoff S.L., Bennett P.H., and Unger R.H. Immunoreactive glucagon (IRG) responses to intravenous glucose in prediabetes and diabetes among Pima Indians and normal Caucasians. J Clin Endocrinol Metab 44 (1977) 968-972
51. Muller W.A., Faloona G.R., Aguilar-Parada E., and Unger R.H. Abnormal alpha-cell function in diabetes. Response to carbohydrate and protein ingestion. N Engl J Med 283 (1970) 109-115
52. Raskin P., Aydin I., Yamamoto T., and Unger R.H. Abnormal alpha cell function in human diabetes: the response to oral protein. Am J Med 64 (1978) 988-997
53. Ward W.K., Bolgiano D.C., McKnight B., Halter J.B., and Porte Jr. D. Diminished cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74 (1984) 1318-1328
54. Consoli A., Nurjhan N., Capani F., and Gerich J. Predominant role of gluconeogenesis in increased hepatic glucose production in NIDDM. Diabetes 38 (1989) 550-557
55. Basu R., Schwenk W.F., and Rizza R.A. Both fasting glucose production and disappearance are abnormal in people with "mild" and "severe" type 2 diabetes. Am J Physiol Endocrinol Metab 287 (2004) E55-E62
56. Baron A.D., Schaeffer L., Shragg P., and Kolterman O.G. Role of hyperglucagonaemia in maintenance of increased rates of hepatic glucose output in type II diabetics. Diabetes 36 (1987) 274-283
57. Parker J.C., Andrews K.M., Allen M.R., Stock J.L., and McNeish J.D. Glycaemic control in mice with targeted disruption of the glucagon receptor gene. Biochem Biophys Res Commun 290 (2002) 839-843
58. Parker J.C., McPherson R.K., Andrews K.M., Levy C.B., Dubins J.S., Chin J.E., et al. Effects of skyrin, a receptor-selective glucagon antagonist, in rat and human hepatocytes. Diabetes 49 (2000) 2079-2086
59. Gysin B., Trivedi D., Johnson D.G., and Hruby V.J. Design and synthesis of glucagon partial agonists and antagonists. Biochemistry 25 (1986) 8278-8284
60. Madsen P., Knudsen L.B., Wiberg F.C., and Carr R.D. Discovery and structure-activity relationship of the first non-peptide competitive human glucagon receptor antagonists. J Med Chem 41 (1998) 5150-5157
61. Conarello S.L., Jiang G., Mu J., Li Z., Woods J., Zycband E., et al. Glucagon receptor knockout mice are resistant to diet-induced obesity and streptozotocin-mediated beta cell loss and hyperglycaemia. Diabetologia 50 (2007) 142-150
62. Gelling R.W., Du X.Q., Dichmann D.S., Romer J., Huang H., Cui L., et al. Lower blood glucose, hyperglucagonaemia, and pancreatic alpha cell hyperplasia in glucagon receptor knockout mice. Proc Natl Acad Sci U S A 100 (2003) 1438-1443
63. Vuguin P.M., Kedees M.H., Cui L., Guz Y., Gelling R.W., Nejathaim M., et al. Ablation of the glucagon receptor gene increases fetal lethality and produces alterations in islet development and maturation. Endocrinology 147 (2006) 3995-4006